Brigid Makes - 07 Jun 2022 Form 4 Insider Report for AZIYO BIOLOGICS, INC. (ELUT)

Reporting relationship: Director
Issuer ticker: ELUT
Reported as of: 07 Jun 2022
Net transaction value: $0
SEC form: 4
Accepted by SEC: 09 Jun 2022, 08:34:48 UTC
Prior SEC filing: 06 Jun 2022
Next SEC filing: 31 Aug 2022
Source filing: View source filing
Reporting owner signature: /s/ Jeffrey Hamet, Attorney-in-Fact for Brigid Makes

Key filing fact

Brigid Makes filed Form 4 for AZIYO BIOLOGICS, INC. (ELUT) on 09 Jun 2022.

Key facts

This page summarizes Brigid Makes's Form 4 filing for AZIYO BIOLOGICS, INC. (ELUT).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 09 Jun 2022, 08:34.

Change

Previous filing in this sequence was filed on 06 Jun 2022.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

AZYO transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value: $0
Shares: +22,090
Change %
Price: $0.000000
Shares after: 22,090
Date: 07 Jun 2022
Ownership: Direct
Underlying class: Class A Common Stock
Underlying amount: 22,090
Exercise price: $6.28
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

This option was granted automatically under the Issuer's Non-Employee Director Compensation Program and vests and becomes exercisable on the earlier of (i) the day immediately preceding the date of the Issuer's first annual meeting following the date of grant and (ii) the first anniversary of the date of grant, subject to the Reporting Person's continuing in service on the Issuer's board of directors through the applicable vesting date.